RFK Jr. Shifts $500 Million From mRNA Research to ‘Safer’ Vaccines. Does the Data Back That Up?
Secretary of the Department of Health and Human Services Robert F. Kennedy Jr. has launched yet another scientifically unjustified attack on promising vaccine research by canceling mRNA vaccine research contracts sponsored by the Biomedical Advanced Research and Development Authority (BARDA).
“We reviewed the science, listened to the experts, and acted,” said Kennedy in a press release. “BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.” In other words, RFK Jr. plans to spend the $500 million from the canceled BARDA contracts on these allegedly safer and broader vaccine platforms.
Really? Consider that in June, vaccine manufacturer Moderna reported the results of a clinical trial pitting its mRNA influenza vaccine against both high-dose and standard-dose licensed seasonal influenza vaccines. The conventional vaccines used inactivated flu viruses to induce an immune response. Mode
Article from Reason.com
The Reason Magazine website is a go-to destination for libertarians seeking cogent analysis, investigative reporting, and thought-provoking commentary. Championing the principles of individual freedom, limited government, and free markets, the site offers a diverse range of articles, videos, and podcasts that challenge conventional wisdom and advocate for libertarian solutions. Whether you’re interested in politics, culture, or technology, Reason provides a unique lens that prioritizes liberty and rational discourse. It’s an essential resource for those who value critical thinking and nuanced debate in the pursuit of a freer society.
